Nebula Research & Development LLC Invests $2.76 Million in Hamilton Lane Incorporated (NASDAQ:HLNE)

Nebula Research & Development LLC purchased a new stake in shares of Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 18,658 shares of the company's stock, valued at approximately $2,762,000.

Several other institutional investors have also recently made changes to their positions in the business. Voya Investment Management LLC lifted its stake in shares of Hamilton Lane by 9.2% in the 4th quarter. Voya Investment Management LLC now owns 13,574 shares of the company's stock worth $2,010,000 after purchasing an additional 1,147 shares during the period. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Hamilton Lane by 1.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 19,880 shares of the company's stock worth $2,943,000 after purchasing an additional 245 shares during the period. T. Rowe Price Investment Management Inc. lifted its stake in shares of Hamilton Lane by 10.0% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 780,363 shares of the company's stock worth $115,533,000 after purchasing an additional 70,976 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Hamilton Lane by 229.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock worth $191,321,000 after purchasing an additional 900,283 shares during the period. Finally, Harvest Investment Services LLC lifted its stake in shares of Hamilton Lane by 97.2% in the 4th quarter. Harvest Investment Services LLC now owns 3,339 shares of the company's stock worth $494,000 after purchasing an additional 1,646 shares during the period. Institutional investors own 97.40% of the company's stock.

Hamilton Lane Price Performance

Shares of HLNE traded down $1.50 during midday trading on Wednesday, hitting $153.01. 130,258 shares of the company traded hands, compared to its average volume of 537,989. The firm has a 50 day moving average of $145.37 and a 200-day moving average of $161.06. Hamilton Lane Incorporated has a 52 week low of $110.90 and a 52 week high of $203.72. The stock has a market cap of $8.48 billion, a price-to-earnings ratio of 28.23 and a beta of 1.32. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.19 and a current ratio of 4.19.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported $1.25 EPS for the quarter, beating the consensus estimate of $1.13 by $0.12. Hamilton Lane had a net margin of 31.12% and a return on equity of 36.69%. The business had revenue of $168.26 million during the quarter, compared to the consensus estimate of $158.86 million. During the same quarter in the prior year, the firm earned $0.71 EPS. The business's revenue was up 34.3% on a year-over-year basis. On average, analysts forecast that Hamilton Lane Incorporated will post 4.97 EPS for the current fiscal year.

Hamilton Lane Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Investors of record on Friday, March 14th were given a $0.49 dividend. This represents a $1.96 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Friday, March 14th. Hamilton Lane's dividend payout ratio (DPR) is currently 36.16%.

Analyst Upgrades and Downgrades

HLNE has been the topic of several recent research reports. Keefe, Bruyette & Woods increased their price objective on shares of Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. decreased their target price on shares of Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating on the stock in a research note on Tuesday. Morgan Stanley decreased their target price on shares of Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating on the stock in a research note on Monday, April 14th. The Goldman Sachs Group cut shares of Hamilton Lane from a "neutral" rating to a "sell" rating and set a $139.00 target price on the stock. in a research note on Monday, January 6th. Finally, Wells Fargo & Company decreased their target price on shares of Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $164.14.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.